SENORESPharmaceuticals
Senores Pharmaceuticals Ltd — PE Ratio & Valuation Analysis
₹759.60
+0.92%
Current P/E42.68xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E67.2x36.4% below avg
⚠️
34.3% Premium to Industry
SENORES P/E 42.68x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹16.12 | ₹822 | 51x |
| 2024 | ₹6.83 | ₹569 | 83.3x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Senores Pharmaceuticals Ltd Valuation
Senores Pharmaceuticals Ltd (SENORES) currently trades at 42.68x earnings. The Pharmaceuticals sector average PE is 31.77x. SENORES commands a premium, reflecting high growth expectations. Historically, SENORES has traded at an average PE of 67.2x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
11.82%
Dividend Yield
0.00%
More on Senores Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.